Search results
CAR-T Treatment Continues to Astonish in Rheumatologic Diseases
MedPage Today· 4 days agoNew data reported here reinforce the idea that chimeric antigen receptor T-cell (CAR-T) therapy can...
Case study reveals important new details about rare second cancers related to CAR-T therapy
Medical Xpress· 3 days agoA new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance ...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters· 1 day agoThe European health regulator said on Friday product information for a class of cancer therapies...
SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell...
Digital Journal· 5 days agoThis type of engineered T -Cell is called CAR-T (Chimeric Antigen Receptor T-Cell). This breakthrough...
Reinvigorating exhausted immune cells reveals potential therapy target for cancer
Medical Xpress· 2 days agoIn working to understand the ecosystem's role in cancer risk, development and treatment, researchers at The Jackson Laboratory have not only identified how two immune cells work together to ...
Engineered γδ T cells show promise in bone tumours - Nature Reviews Immunology
Nature· 5 days agoAn adoptive cellular therapy based on γδ T cells, which were engineered to secrete a tumour-targeting opsonin as well as an IL-15 superagonist, controlled tumour growth in a mouse model of patient-derived osteosarcoma.
Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespan
Science Daily· 4 days agoScientists at St. Jude Children's Research Hospital and the University of Minnesota investigated the unique 'epigenetic clock' of T-cell aging, demonstrating ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caribou...
Morningstar· 9 hours agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Caribou Biosciences, Inc. ("Caribou" or the "Company") (NASDAQ: CRBU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.
Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespan
Medical Xpress· 3 days agoScientists at St. Jude Children's Research Hospital and the University of Minnesota investigated the unique 'epigenetic clock' of T cell aging, demonstrating ...
How Glowing Dye That Clings to Cancer Cells Gives Doctors ‘second pair of eyes’
GoodNewsNetwork· 2 days agoDeveloped for use in the removal of prostate cancer, the dye could be adapted to other cancers but...